Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Dmv-Fonterra Excipients Technology Gmbh, , Glaxo Group Limited patent solves the following problem:

In the field of inhalation therapy, it is generally desirable to use therapeutic molecules having a particle size (ie, diameter) in the range of 1 to 10 m. carrier molecule or excipients, such as lactose, canine therapeutic preparation also includes significantly larger diameter particles (for example, 100 to 150 m) which are not normally penetrate into the upper respiratory tract to the same degree as the active ingredient. In general, it is better to use a smaller particle size for the lactose or a lactose blend having a defined ratio of coarse and fine lactose.

Our analysis of this patent is as follows:

Dmv-Fonterra Excipients Technology Gmbh, , Glaxo Group Limited’s patent US 9365905 B2 deals with Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom.
A process for forming lactose suitable for use in a pharmaceutical formulation comprises providing a plurality of lactose particles containing no more than 10% w / w of lactose particles with a number average the particle size of about 70 microns or less; stands the plurality of lactose particles to yield a plurality of milled lactose particles with an average particle size, (D50), from 50 micron to 100 micron; and classifying the plurality of milled lactose particles at least two pieces consisting of a fine particle and a coarse particle in which the fine particle has an average particle size, (D50), from 3 microns to 50 microns, and the coarse particle has an average particle size, (D50), from 40 micron to 250 micron.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Pyrazolyl derivatives as Syk inhibitors

File for Quick & Easy Patent Protection with PowerPatent.

The Merck Sharp & Dohme Corp., , Merck Canada Inc. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp., , Merck Canada Inc.’s patent US 9242984 B2 deals with Pyrazolyl derivatives as Syk inhibitors.
The present invention provides new pyrazole derivatives of formula I are potent inhibitor of spleen tyrosine kinase, and is useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer .

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Compositions having reduced frictional coefficient, method of manufacture thereof and articles comprising the same

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Sabic Global Technologies B.V. patent solves the following problem:

It disclosure relates to compositions that reduce frictional coefficients, means to do so, and articles comprising the same.

Our analysis of this patent is as follows:

Sabic Global Technologies B.V.’s patent US 9169371 B2 deals with Compositions having reduced frictional coefficient, method of manufacture thereof and articles comprising the same.
Expressed here is a composition consisting of an organic polymer and about 2 to 10 weight percent of an ionic liquid. The ionic liquid can be a halogenated or non-halogenated ionic liquid. Also disclosed in articles made from the composition.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Endpoint-hosted hypervisor management

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The International Business Machines Corporation patent solves the following problem:

The invention relates to the electronic network. Particularly, the invention relates to the endpoint host hypervisor management.

Our analysis of this patent is as follows:

International Business Machines Corporation’s patent US 9055386 B2 deals with Endpoint-hosted hypervisor management.
A client hypervisor consists of a virtual agent that runs out of a system of the OS, and that allows to manage devices independent of the OS and the user. The virtual agents tied to one device and not to a specific time of the OS. Such client hypervisors expose new functionality to ease system management. Some of these capabilities from endurance and privileges without the OS. In some embodiments of the invention, this new management functionality to spread the rule of the device with new virtualization concepts, such as the number of VMs per system, VM instead, snapshot / rollback, etc.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Merck Sharp & Dohme Corp. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp.’s patent US 9006444 B2 deals with Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors.
invention provides certain phenyl formamide-containing compounds of Formula (I); or pharmaceutically acceptable salts thereof, wherein A and B as described here. invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated spleen tyrosine kinase (SYK) kinase.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Merck Sharp & Dohme Corp. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp.’s patent US 8987456 B2 deals with 3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors.
invention provides certain 3-pyridyl formamide-containing compounds of Formula (I) (I) or pharmaceutically acceptable salts thereof, wherein A and B as described here. invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated spleen tyrosine kinase (SYK) kinase.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Tunable resonant leaky-mode N/MEMS elements and uses in optical devices

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The University Of Connecticut patent solves the following problem:

The present invention generally relates to a strategic new field Optical devices based on sound dripped through each modulated films. Particularly, the present invention relates to tunable optical devices based on known nano / micro-electromechanical (N / MEMS) actuation methods, and the practical application thereof.

Our analysis of this patent is as follows:

University Of Connecticut’s patent US 8938141 B2 deals with Tunable resonant leaky-mode N/MEMS elements and uses in optical devices.
Mechanically tunable electromagnetic and photonic devices showed enhanced spectral tunability with minimal mechanical activity given. These nano / micro-electromechanically (N / MEMS) tunable elements, including filtering and pixels, rely on drop-mode resonance effect of subwavelength photonic lattices containing each wavelength. These elements act in reflection (bandstop) or transmission (bandpass) method, and can be arranged in one-dimensional or two-dimensional arrays, or moved as single units, and their spectral region controlled design elements. Input electromagnetic radiation illuminates the elements and then filtered, modulated, or listened analysis by the elements. Mechanical motion to change the structural balance, and therefore, the properties do, the nanostructured elements subwavelength resonance. Furthermore, the use of metals and dielectrics to produce live together plasmonic and drop-mode resonance effect adds to the versatility of potential applications.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Lid for closing a cup

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Constantia Teich Gmbh patent solves the following problem:

Our analysis of this patent is as follows:

Constantia Teich Gmbh’s patent US 8905251 B2 deals with Lid for closing a cup.
A lid (2) for the end of a cup (1) by a peripheral sealing edge (10) and a method for the production of such a lid. lid includes at least one aluminum film and an optionally multi-layered plastic layer that is co-extruded film to aluminum and has a closed predetermined tear lines (3). The plastic layer made of plastic based on polyethylene (PE) or plastic based on polypropylene (PP), and the predetermined tearing line introduced into the plastic layer preferably with a CO2 laser. The predetermined tear lines (3) can be given directly to the sealing edge region (10).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Merck Sharp & Dohme Corp. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp.’s patent US 8796310 B2 deals with Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors.
invention provides certain amino-pyridine-containing compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, P3, R4, R5, R6, R7, R8, R9, and n are as described here. invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated spleen tyrosine kinase (SYK) kinase.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Integrated emergency medical database system

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Golden Hour Data Systems, Inc. patent solves the following problem:

This invention relates to an integrated system of medical database. More specifically, this invention relates to a medical database for emergency medical transportation industry.

Our analysis of this patent is as follows:

Golden Hour Data Systems, Inc.’s patent US 8712793 B2 deals with Integrated emergency medical database system.
An integrated medical database system for business emergency medical transportation disclosed. The system includes a dispatch module, clinical module, administration module and billing module. Each module to communicate data with one or more other modules to form a system for use in data sharing, thus achieving an end-to-end automation emergency care in medical accounting. Internal consistency checks made by the system to ensure that proper treatments made according to a choice diagnosis.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.